The efficacy comparison of carvedilol plus endoscopic variceal ligation and traditional, nonselective β-blockers plus endoscopic variceal ligation in cirrhosis patients for the prevention of variceal rebleeding: a meta-analysis
Carvedilol was more efficacious than traditional NSBBs in decreasing the variceal rebleeding rate [odds ratio (OR): 0.75; 95% confidence interval (CI: 0.38-0.75, P = 0.0003), lowering the degree of esophageal varices (OR: 4.40, 95% CI: 2.64, P < 0.00001) No difference was noted between carvedilol and traditional NS BBs with respect to mortality and heart rate.
